ENHYPEN ascends to the top of the Billboard Artist 100 chart for the first time, re-entering at No. 1 on the Jan. 31, 2026-dated chart following opening-week performance of its new EP THE SIN : VANISH. The milestone helps the group become the top musical act in the U.S. for the first time.
Released Jan. 16 via BELIFT LAB/Geffen/Interscope Capitol, the set debuts at No. 1 on the Top Album Sales chart with 113,000 copies sold in its first week of release, according to Luminate. With the debut, ENHYPEN’s earns its fourth No. 1 on Top Album Sales, after MANIFESTO : DAY 1 (2022), ROMANCE : UNTOLD (2024) and DESIRE : UNLEASH (2025).
Beyond its sales success, THE SIN : VANISH also opens at No. 2 on the Billboard 200, becoming ENHYPEN’s ninth career entry on the chart and matching its 2024 set ROMANCE : UNTOLD as the group’s highest-charting effort. The band has steadily climbed the Billboard 200 since its 2021 debut, with its past six chart appearances reaching the top 10. Here’s a look at ENHYPEN’s full history on the Billboard 200:
No. 18, BORDER : CARNIVAL, May 29, 2021
No. 11, DIMENSION : DILEMMA, Oct. 30, 2021
No. 14, DIMENSION : ANSWER, Jan. 29, 2022
No. 6, MANIFESTO : DAY 1, Aug 13, 2022
No. 4, DARK BLOOD, June 17, 2023
No. 4, ORANGE BLOOD, Dec. 2, 2023
No. 2, ROMANCE : UNTOLD, July 27, 2024
No. 3, DESIRE : UNLEASH, June 21, 2025
No. 2, THE SIN : VANISH, Jan. 31, 2026
On Billboard’s song rankings, ENHYPEN’s “The Knife” debuts at No. 62 on the Global Excl. U.S. chart and No. 90 on the Billboard Global 200. It earns the group its eighth entry on Global Excl. U.S. and fifth on the Global 200. “The Knife” also arrives at No. 1 on the World Digital Song Sales chart, thanks to 1,000 downloads sold in the tracking week, becoming the group’s first No. 1 on the chart.
The Artist 100 measures artists’ activity across key metrics of music consumption: album sales, track sales, radio airplay and streaming. Using a methodology comprising those metrics, the chart provides a weekly multi-dimensional ranking of artist popularity.
